Home » Topics » BioWorld Science

BioWorld Science
RSS

Gluk2-targeted siRNA-based gene therapy for drug-resistant temporal lobe epilepsy

Oct. 26, 2021

AKAP11 identified as shared risk gene in bipolar disorder and schizophrenia

Oct. 26, 2021

Kinsensus Limited describes new MERTK/AXL inhibitors

Oct. 26, 2021

New HLA-DRB1 ligands identified at Janssen Pharmaceutica

Oct. 26, 2021

New CD80/PD-L1 and/or PD-1/PD-L1 interaction inhibitors discovered at Bristol Myers Squibb

Oct. 26, 2021

Thomas Jefferson University, Context Therapeutics patent androgen and SIGMAR1 receptor antagonists

Oct. 26, 2021

Janssen BioPharma presents compounds for inhibiting respiratory syncytial virus replication

Oct. 26, 2021

Repurposing bumetanide for the treatment of APOE4-related AD

Oct. 26, 2021

CS-5001, novel ADC with promising efficacy in models of ROR1-expressing cancers

Oct. 26, 2021

New human SARS-CoV-2 vaccines based on AAV vectors presented

Oct. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...